<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for The Fryern Surgery</h1>
        This is some intro text. Please fill in our feedback <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=%20">survey</a>.

        <h2>Prescribing where The Fryern Surgery is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0106040J0&amp;denomIds=1.6.4&amp;selectedTab=summary">Magnesium hydroxide</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Osmotic laxatives</td>
      <td>1131</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>7.65</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0106040J0AAAIAI&amp;denomIds=1.6.4&amp;selectedTab=summary" target="_blank">Magnesium hydroxide 8% oral suspension : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0106040J0&amp;denomIds=1.6.4&amp;selectedTab=summary">Magnesium hydroxide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Osmotic laxatives</td>
      <td>1131</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>7.65</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0106040J0AAAIAI&amp;denomIds=1.6.4&amp;selectedTab=summary" target="_blank">Magnesium hydroxide 8% oral suspension : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205051AC&amp;denomIds=2.5.5&amp;selectedTab=summary">Perindopril with calcium channel blocker</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Angiotensin-converting enzyme inhibitors</td>
      <td>2943</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>7.34</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205051ACAAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Perindopril erbumine 4mg / Amlodipine 5mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205051AC&amp;denomIds=2.5.5&amp;selectedTab=summary">Perindopril with calcium channel blocker</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Angiotensin-converting enzyme inhibitors</td>
      <td>2943</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>7.34</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205051ACAAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Perindopril erbumine 4mg / Amlodipine 5mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0212000A0&amp;denomIds=2.12&amp;selectedTab=summary">Acipimox</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Lipid-regulating drugs</td>
      <td>4322</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>9.21</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0212000A0AAAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Acipimox 250mg capsules : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0212000A0&amp;denomIds=2.12&amp;selectedTab=summary">Acipimox</a><button type="button" data-toggle="collapse" data-target="#table_high_5_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Lipid-regulating drugs</td>
      <td>4322</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>9.21</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_5_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0212000A0AAAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Acipimox 250mg capsules : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409010S0&amp;denomIds=4.9.1&amp;selectedTab=summary">Tolcapone</a><button type="button" data-toggle="collapse" data-target="#table_high_6_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Dopaminergic drugs used in parkinsonism</td>
      <td>402</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>12.45</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_6_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409010S0AAAAAA&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Tolcapone 100mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409010S0&amp;denomIds=4.9.1&amp;selectedTab=summary">Tolcapone</a><button type="button" data-toggle="collapse" data-target="#table_high_7_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Dopaminergic drugs used in parkinsonism</td>
      <td>402</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>12.45</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_7_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409010S0AAAAAA&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Tolcapone 100mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409030B0&amp;denomIds=4.9.3&amp;selectedTab=summary">Botulinum toxin type A</a><button type="button" data-toggle="collapse" data-target="#table_high_8_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>24</td>
      <td>Essential tremor,chorea,tics and related disorders</td>
      <td>43</td>
      <td>0.56</td>
      <td>0.0</td>
      <td>0.04</td>
      <td>13.70</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_8_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409030B0BEABAD&amp;denomIds=4.9.3&amp;selectedTab=summary" target="_blank">Xeomin 50unit powder for solution for injection vials : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409030B0AAADAD&amp;denomIds=4.9.3&amp;selectedTab=summary" target="_blank">Botulinum toxin type A 50unit inj vials : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409030B0AAAEAE&amp;denomIds=4.9.3&amp;selectedTab=summary" target="_blank">Botulinum toxin type A 100unit inj vials : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409030B0BEAAAE&amp;denomIds=4.9.3&amp;selectedTab=summary" target="_blank">Xeomin 100unit powder for solution for injection vials : 20</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409030B0&amp;denomIds=4.9.3&amp;selectedTab=summary">Botulinum toxin type A</a><button type="button" data-toggle="collapse" data-target="#table_high_9_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>24</td>
      <td>Essential tremor,chorea,tics and related disorders</td>
      <td>43</td>
      <td>0.56</td>
      <td>0.0</td>
      <td>0.04</td>
      <td>13.70</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_9_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409030B0BEABAD&amp;denomIds=4.9.3&amp;selectedTab=summary" target="_blank">Xeomin 50unit powder for solution for injection vials : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409030B0AAADAD&amp;denomIds=4.9.3&amp;selectedTab=summary" target="_blank">Botulinum toxin type A 50unit inj vials : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409030B0AAAEAE&amp;denomIds=4.9.3&amp;selectedTab=summary" target="_blank">Botulinum toxin type A 100unit inj vials : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0409030B0BEAAAE&amp;denomIds=4.9.3&amp;selectedTab=summary" target="_blank">Xeomin 100unit powder for solution for injection vials : 20</a></div></td></tr></tbody></table>

        <h2>Prescribing where The Fryern Surgery is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0202020L0&amp;denomIds=2.2.2&amp;selectedTab=summary">Furosemide</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>574</td>
      <td>Loop diuretics</td>
      <td>950</td>
      <td>0.60</td>
      <td>0.86</td>
      <td>0.09</td>
      <td>-2.81</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0202020L0AABBBB&amp;denomIds=2.2.2&amp;selectedTab=summary" target="_blank">Furosemide 20mg tablets : 256</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0202020L0AABDBD&amp;denomIds=2.2.2&amp;selectedTab=summary" target="_blank">Furosemide 40mg tablets : 307</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0202020L0AABQBQ&amp;denomIds=2.2.2&amp;selectedTab=summary" target="_blank">Furosemide 20mg/5ml oral solution sugar free : 11</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0202020L0&amp;denomIds=2.2.2&amp;selectedTab=summary">Furosemide</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>574</td>
      <td>Loop diuretics</td>
      <td>950</td>
      <td>0.60</td>
      <td>0.86</td>
      <td>0.09</td>
      <td>-2.81</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0202020L0AABBBB&amp;denomIds=2.2.2&amp;selectedTab=summary" target="_blank">Furosemide 20mg tablets : 256</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0202020L0AABDBD&amp;denomIds=2.2.2&amp;selectedTab=summary" target="_blank">Furosemide 40mg tablets : 307</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0202020L0AABQBQ&amp;denomIds=2.2.2&amp;selectedTab=summary" target="_blank">Furosemide 20mg/5ml oral solution sugar free : 11</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205052N0&amp;denomIds=2.5.5&amp;selectedTab=summary">Losartan potassium</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>251</td>
      <td>Angiotensin-II receptor antagonists</td>
      <td>1420</td>
      <td>0.18</td>
      <td>0.50</td>
      <td>0.19</td>
      <td>-1.73</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAIUElEQVR4nO2df6xXZR3HXwewAJV+sJJ+IE+KZlYiUS4QA5nDuaOsrFXLFjoSctkvt+Rppq023UH6A62Vy3Tq1Mlo6ZpnqKGAcYVK/IFlCpSHHInQEiUNSn364/Owe+/Xe+Xe+z3f73POeT6v7dl3sHu/3/e997zO85znZ+KcQ1GUOBgVOoCiKN1DhVeUiFDhFSUiVHhFiQgVXlEiQoVXlIhQ4RUlIlR4RYkIFV5RIkKFV5SIaL7wSaJzhxXFMyZ0AKW+GJu/AzgJOBb4ADAReLsvbwPGtnzL68DLwL/7lF1A4csOYEeRpf/tfPo4SRq/eCZJHM4loWM0AS/4GcBZwBzgNWALsA14BtgDvAjs9a/7gb4X2GhgPHBEn/IewABT/OsxwHPA74H7gQeKLN3b0R8sIlR4ZVCMzUcBJyOCnwW8H/gtcA9wfydENDZPEPlnIjeXecB2YBWwqsjSF8r+zJhQ4ZV+GJu/E5iPCH46Its9wGrgT0WWdvWC8TedU4AvAJ8F1gE/LbL0D93M0RRU+MgxNj8cmIU00ecBk5BafDVSi+8LGK8fxuZvBT4DfAd4BbgKWNPtm1CdUeEjw9j8COBUYC4i+WRgI1JzrgP+UnWBfLN/DvADpI/Aao0/NFT4hmNsPgGYjQgyB3gv0AOsRwR/uuqCD4YXfz5wNfAwIv6esKmqjQrfMIzNxwCfQESYj3S0/Q4RfD2wra6CD4ax+WHA14FvA98Hbmvaz1gWKnwDMDafgsh9JtK7vQW4F7iPGjTRy8LY/Gjgl8jz/YVa278RFb6G+OfwufTW4vsRue8DNhRZuj9curD4Zv5FwCXAV4osfShwpEqhwteAPuPhZyKCT0Wa5/civdTPBYxXSYzNZwC3Az8HromllXMoVPgK4mup45Fa/HSkV30rvbX440WWvh4sYE3wMwNvQVpAi4osfSlwpOCo8BXAC34c0ot+UPB/IL3oa4GeIktfDhawxvjW0aXAecCCIkufCRwpKCp8l/FyG2AG8HH/eiLwd3qHynqqNOGlCRibLwBWAF8qsnRT6DyhUOE7iJf7aPrL/RFgJzJuvNm/Pllk6f9CZIwJY/OPIXPybZGlq0LnCYEKXyJ+HvpM4JOI4B9Fln8eFHszMh9dl38Gwth8MvAbYCWwLLbOPBV+hPR57j7Vl1nAYcBDwCbgj8ATRZYeKPuzlfYwNj8SuANZhntRTK0rFX6IGJuPRWrtWYjgM4BnkWmqPcDGIkt3tfs5SnfwMxKvAT4IfC6WNfcq/CAYmx9Fr9yzkGfxzUgN3gM8HPMElybgW2nfAhYRSQ9+9ML7P/pkZGLLycB0YBpwABH7oOBbY3veiwVj83OQ2v68Iks3hs7TSaIS3i+yOIH+cp+APMs95sujwBadpBEXxubTkR78y4osXRk6T6dotPDG5hOLZWf/0yy9+8fAaUiz/Cl65X4MWVwSTaeNMjjG5u9DevDvBK5sYouuUcL75vl04FxgATCuWHb2VLP07q8iS0QbtzRUKRe/MOl24AVgcdNGWRohvLH5ROAC4HzkD/Ur4K4iS3dUbaadUn2MzUcDy5FRmc83afSl1sL7deCXIPuc3QrcWGTp9n5fpMIrI8TY/HzgcmBhkaUbAscphVoKb2x+ImCR4bJrgRsGXVyiwitt4Dvz7gB+Blxb90fCWgnvO1V+hExfvQpYecgONxVeaRO/zPZW4CVgSZ1HcGohvN+I8eASx+XA9UPuWVfhlRLwy2yXIn1FXyuy9IHAkUZEpYX34+YXAt8FbgOuHvbdVYVXSsTYfBpwE7ABWXVXq30KKim8H177NHAlsmf6FUWW7hzRm6nwSskYm78FuAI5CWdJkaUPBo40ZConvLH5bCAD9gGXFln6RFtvqMIrHcLY/BRkz7ytyLX6bOBIh6QywhubHzxJZBxweZGla0p5YxVe6SB+zP4C4DJkhl5WZOnusKkGJ6jwvuk+DxnrHA38EDnPrLxQKrzSBYzNxyOHYVyMnMu3osjSp8KmeiNBhDc2fzfwRWAJst1TBqztyBinCq90EWPzccCXgW8Ae4GbgV9X5ZjrrgjfZ3eY+cgc96nI9Nfriyzd1tEPV+GVAPhrfgawEDgH+Bty7PZ64JFQC7ZKFd4f53uUL1OR3USm+7ILOThhNbCpa/uqq/BKYPrIfwayFfk0YA/wJPBn/7oTceT5Tm6s0pbwxuYPAuOBCb4cAHYDzwN/BZ4GHgceLbL0lbbTjgQVXqkY/gYwCdme/MPAh5BTfSchleVY4D/IGXkDlVd9eQ14tcjSi4f62W0JnyTJYufcL0b8BoHQ3N1Fc1eHUW1+/+JSUnQfzd1dNHdFaFd4RVFqhAqvKBHRrvB1fb7R3N1Fc1eEykytVRSl82iTXlEiYsxwvjhJkk8h20rtds7dmCTJucCxwHbn3J2dCFgGA+ReiIx/rnbOrQ2b7s1pze7/7zrgJudcZY89HuB3fhqyU9Em51xll5MOkHsRcCSAc25F0HAlMNwafqZzLgPe5f99nHNuOXB8ubFKp19u59zNwHXAMUFTDY1+2f1Ndl3QREOj9VpZgEwm6c4My5HTmns0MhmmsivghsNwhW994K9LB0C/nEmSHI6cJ3ZLmDjDovV3fBIwGznzrsq05p7gnPsJsp6iyrTmHuWc+x7Skq09w+q0882dmcC/gEeAKcgvYptz7q6OJCyBAXJ/E9gOrHHOVfossdbszrnNSZLMBfbXoEnfeq0Y4EXn3A0Bo70pA+SeAyTAvibMutNeekWJCO2lV5SIUOEVJSJUeEWJCBVeUSJChVeUiFDhFSUiVHhFiQgVXlEiQoVXlIhQ4RUlIlR4RYmI/wO0PYf2BYnWnQAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205052N0AAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 25mg tablets : 44</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205052N0AAABAB&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 50mg tablets : 106</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205052N0AAADAD&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 100mg tablets : 82</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205052N0AAAHAH&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 12.5mg tablets : 19</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205052N0&amp;denomIds=2.5.5&amp;selectedTab=summary">Losartan potassium</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>251</td>
      <td>Angiotensin-II receptor antagonists</td>
      <td>1420</td>
      <td>0.18</td>
      <td>0.50</td>
      <td>0.19</td>
      <td>-1.73</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205052N0AAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 25mg tablets : 44</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205052N0AAABAB&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 50mg tablets : 106</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205052N0AAADAD&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 100mg tablets : 82</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0205052N0AAAHAH&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 12.5mg tablets : 19</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0&amp;denomIds=5.3.2&amp;selectedTab=summary">Aciclovir</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>100</td>
      <td>Herpes simplex and varicella-zoster</td>
      <td>120</td>
      <td>0.83</td>
      <td>0.95</td>
      <td>0.07</td>
      <td>-1.76</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAFaUlEQVR4nO3dW4gWZRzH8e+sawfSJczcCyWHhI4eIqKyk0JkxUCYeWF0Qg2piyS6mi6CLjoMXUTQTVSWdddhK6QxwSLzgBtYdJEFRTqBBomH9QBFav8unnlrtXfdXXdO+z6/Dwzvvi/s8/wu9sfzvLMz7xuYGSLih666A4hIdVR4EY+o8CIeUeFFPKLCi3hEhRfxiAov4hEVXsQjKryIR1R4EY+o8NI5gkDXiQ+ju+4AIjK8ME6vAN4E9mdJtPhsx1HhRcaHx4F1wJaxDBLobjnpGEFgmAV1xyhaGKfnAj8Ds7MkOjKWsfQeXqT5FgNfjrXsoMKLjAcrgDVFDKTCizRYGKczgZmM8b17iwov0myPAO9kSVTIyTadpRdpqDBOA+AhYEFRY2qFF2mua4G9WRL9VtSAKrxIcy0FPihyQG3pRRoo387fBywsclyt8CLNNA/4vcjtPKjwIk21FPiw6EG1pRdpmEHb+TuKHlsrvEjzzAYOZUm0p+iBVXiR5nmQgs/Ot2hLL9IgYZxOBZYBc8sYXyu8SLM8BbyRJdHhMgbXCi/SEPnq/gAlre6gFV6kSUpd3UErvEgj5LfBlrq6g1Z4kdqFcToL2Ag8UebqDlrhRWoVxunlQAqszpJofdnzqfAiNQjjdArwJO4DLh7NkmhjFfOq8CIVCuN0DrAcd+ns28A1WRIdqmp+FV6kZGGcXgTcjyv6SVzR52VJNFB1FhVepARhnHYDi3Alvx54H3g4S6KddebSF1FI56j5iyjCOO0CbsJt1+8FdgBrgQ1ZEp2oK9dgKrx0jhoKn6/kC4ElQATsBD4CPs6S6ECVWUZChZfOUVHhwzg9D7id/+5Z3wH0AZ/W8b58NFR46RwlFj6M0+m4FTwCrsN9MUQf8FmWRMfKmLMMKrx0jgILH8bpNGA+7j35ncBEYD3uIpltWRIdL2Keqqnw0jnOovD5x0lNA64ErgZuzI8TwPb8+DxLot0Fp62FCi+dY4jCh3HaA8wApg96DHElvxQ4APwI/AB8DfRnSXSwotSV0v/hZVwK43QCMAnoAS4GZmTu9ec5tdhTgMPA3vzYkz+uA14CdjXlX2ZVUOGlFPlWeQLub2ziaUc3cA4wGVfYntN+Huq1yfnRhbti7RhwBNiPKzHAbtwJtVa5B4r6IsZOMKotfRind7d+r+RHzVH8HN35MWHQz+2eD1XQ4V5raf1BBbhSHm9znAD+Ao7iCts6RvL8WJZEJ2mn5gtvxgUzq+wAVlU5n7Ioi7KcelT9ARirKp7vTJSlPWVpryOy6BNvRDyiwot4pOrCv17xfGeiLO0pS3sdkUUX3oh4RFt6EY+UeuFNEAS34W4+2Gdmb+WvvQasNbP+MuceLksQBM8CA8B6M/up5iy34m7U6DezzTVnWQxcBZxvZs/UnGUl7kIbzOyVmrOsAC4EfjWzviqz5HkWAo+Z2bL8+UqgF/jKzLaNdJyyV/j5ZpbgLn0kCIIlwKaS5xxRFtz10xc0JMs9wB/A33VnMbNPgF+A9+rOgrsoqBfY14Asl5jZy8BdNWTBzDYB3w16aaqZvQDcMppxyi786ScI5uIC3lzyvMNmMbNXgReBpXVnAXryPIsakAVgjpl9X3mS/2fpMrOngVkNyPJFEASrcdflN8FZnXwr9aRdvi2aDxwEvjWzb/KtyZ81ben/zQJchrsdcquZbag5y0zc3VuHzWxNzVl2Acvz1axSbbIswF2ie9TMKj1L3ibLJOAGYLuZbakyS55nHvAc0A+8i/uknV5g82i29DpLL+IRnaUX8YgKL+IRFV7EIyq8iEdUeBGPqPAiHlHhRTyiwot4RIUX8YgKL+IRFV7EI/8AWKGtqTbss7MAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAABAB&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg tablets : 33</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAACAC&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg tablets : 42</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAAGAG&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg dispersible tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAAEAE&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg dispersible tablets : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAAHAH&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg dispersible tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAADAD&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg tablets : 17</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0&amp;denomIds=5.3.2&amp;selectedTab=summary">Aciclovir</a><button type="button" data-toggle="collapse" data-target="#table_low_5_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>100</td>
      <td>Herpes simplex and varicella-zoster</td>
      <td>120</td>
      <td>0.83</td>
      <td>0.95</td>
      <td>0.07</td>
      <td>-1.76</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_5_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAABAB&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg tablets : 33</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAACAC&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg tablets : 42</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAAGAG&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg dispersible tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAAEAE&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg dispersible tablets : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAAHAH&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg dispersible tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0503021C0AAADAD&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg tablets : 17</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0906050P0&amp;denomIds=9.6.5&amp;selectedTab=summary">Vitamin E</a><button type="button" data-toggle="collapse" data-target="#table_low_6_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Vitamin E</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.73</td>
      <td>0.41</td>
      <td>-1.78</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_6_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=0906050P0&amp;denomIds=9.6.5&amp;selectedTab=summary">Vitamin E</a><button type="button" data-toggle="collapse" data-target="#table_low_7_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Vitamin E</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.73</td>
      <td>0.41</td>
      <td>-1.78</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_7_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=1001022K0&amp;denomIds=10.1.2&amp;selectedTab=summary">Methylprednisolone acetate</a><button type="button" data-toggle="collapse" data-target="#table_low_8_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Local corticosteroid injections</td>
      <td>96</td>
      <td>0.00</td>
      <td>0.73</td>
      <td>0.39</td>
      <td>-1.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_8_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82019&amp;numIds=1001022K0&amp;denomIds=10.1.2&amp;selectedTab=summary">Methylprednisolone acetate</a><button type="button" data-toggle="collapse" data-target="#table_low_9_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Local corticosteroid injections</td>
      <td>96</td>
      <td>0.00</td>
      <td>0.73</td>
      <td>0.39</td>
      <td>-1.87</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAGiklEQVR4nO3d348dYxzH8ff0x/qxtBRtCTpRWiVEUbK0fpfWII24dyHBhbhkLt2ZxKUbkRD8A0Q7JWhJVZRGSSvabnsxiGBL29WU/uJx8X02PT09m57uOZ3nnH0+r+TJzG42289289lnzsycZxLnHCIShymhA4hIfVR4kYio8CIRUeFFIqLCi0REhReJiAovEhEVXiQiKrxIRFR4kYh0Vvgk0X25In1kWugAIjFJ8/Is4BI/Zo+zPwuYik3IYyNp+ngKcAzYWxXZve3++yq8SJeleXk2cDWwELjWbxcCVwJHgD3AiN+O7Q8DX/j9fcBR4D/A+W2rMYD9cWhb0tG75ZLE4Vwy8W8g0r/SvJwGXAfcBlyPlXsBMB3YBexsGj9VRfZvmLRGhRdpQ5qXCTZD3+bH7dgsvh3YDGzFSj1cFdmBUDlPRYUXacEflg8BS7GC3wT8Dnztx1fAzqrI/gsWcgJUeBEgzcsBYAlwL3Afdmj+FbDBb7+riuxQuITdocJLlNK8nAosxsp9H3ADsAVYD3wKbO232bsdKrxEI83Ly4CVfgwB32PlXg9sqYrsWMB4tVDhZdJK83I6Vuyxkg8AH/jxeVVkhwPGC0LX4WVSSfPyUmAF8DBwB3aYvhZYVRVZFTBaT9AML33NXy5bDDzqx3nYDL4Wm8X7/kRbN6nw0nfSvDwHO9H2KDabV8BqYHVVZMMBo/U8FV76QpqXc4FHsJLfil0uWw18WBXZ3pDZ+okKLz0pzcspwM1YyTNgBlBiJd9YFdnRgPH6lgovPSPNy/OBB7CSL8fuR18DlDpU7w4VXoJK83I+x2fxRcA6rOQfV0U2GjLbZKTCS638tfE7OV7yf7BD9TXA5sl4d1svUeHljEvz8mLsxpdHsLJ/gxV8bVVkv4TMFhsVXrrOn3BbDDyElXwOdm18DfCZro2Ho8JLV6R5mWIn2pZjs/gO4COs5D9URab1D3uACi8TkublBdjNL8uB+4GDwCfAx9hls78DxpNxqPDSljQvL8Rm7mXA3dhh+nqs5OuqIhsJGE/apMJLS/7OtmXAXX6cB2wEPsfuctulw/T+o8LL2Em2a7F12pb68S9W7A3Ym1B+DpdQukWFj4x/d9nl2DptS/x2EXZX22ZsFt9YFdmeYCHljFHhJzFf7suw5Ztuwcq9GPiT44sxfg1sj2G1F1HhJ400LwextdFv9OMG7OEHI9gSyt9yfDFGnUGPlArfZ9K8nIWtqDo2FmHlHsDWaNsKbPPbYb2rTBqp8D3IX+NOgWs4sdzzgP3Y6+1hP3YA26oi2x8krPQVFb5m/oz4pdhTTOb5cWXDdjYwiq3i0ljsYexRRXqtLROmwneJX3ZpDjAXK3Sr7VzsqaC/AT8CP/lt4/4eXd+WM0WFb+AfDjjDj5kN40LgonHGLGz130PYCbJfsUK32o5URXakvp9I5ER9VXh/mWk6cG7DGGz6+FRjsGl/JlbwqdjNJn9hh9SjDfv7sEtZzeMP7PncOjEmfaHjwqcvrnkem+GmNm0b9wdajLPG+XzzaPyDkgCHgb/bGAfb/JpR4IBeG0sMuvEgivOBY9js+E/D/rGG/cPAkVOMVl9zVCugiHRPXx3Si0hnpoQOICL16ajwCTzTrSATzpAkT4fOAMrRaxlAOVrpdIbvhR+kFzKAcjTqhQygHCfRIb1IRFR4kYh0WvjXu5KiM72QAZSjUS9kAOU4SWeX5USkr+iQXiQip3WnXZIkdwF3ACPOuTeTJHkcmA/sds69eyYCtpljFbDCOfdswAxPYivOfOCc+zRgjpXYMlbbnHOrQ+Xwn3sNeMs5tylEhiRJXsLWD1jrnKvt6bMtciwDhoBNzrkNdeVo5XRn+CHnXAFc4j++xjn3CrY4Q51OyOGcew97/3jIDG8DrwFXhcwBbAKuwN69FyyHnww+C5kBe4PTYM0ZWuV4DLvtPPht4qdb+OYX/KFOAPTCiYcTMiRJMgg8BbwTModzbh/wHPX/4Wn+ndyILXd9Z6gMzrlXgZeBJ2rMcFIOYIbP8mDNOU5yWift/KHKELAX2IKt0jIf2OVn2Vq0yHEu8AJQOOe+CJTheWA38Ilz7ss6MoyT4ybsd7LJOfd+qBzOuW+SJLkHOFTzIX3j/8UC7GXWRufch3VkGCfHPGzJslHn3Bt15WhFZ+lFIqKz9CIRUeFFIqLCi0REhReJiAovEhEVXiQiKrxIRFR4kYio8CIRUeFFIqLCi0Tkf/0V70Ts/YJIAAAAAElFTkSuQmCC"></td>
    </tr>
  <tr id="table_low_9_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>